-+ 0.00%
-+ 0.00%
-+ 0.00%

ANNJI PHARMACEUTICAL <7754.TWO> SUBMITS APPLICATION TO U.S. FDA FOR PHASE 3 CLINICAL TRIAL OF AJ201 FOR KENNEDY’S DISEASE

路透·09/03/2026 07:57:46

登錄查看新聞詳情